RBR-3q9zb73招募中Unknown

Flow modification in the treatment of Distal Intracranial aneurysms using Dual versus Mono-antiplatelet therapy Randomized trial

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo0 个研究点开始时间: 2023年5月15日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Patients between 18 and 80 years old inclusive; Patients with an unruptured aneurysm of one of the following locations: internal carotid artery, middle cerebral artery, anterior cerebral artery, vertebral artery, basilar artery, posterior cerebral artery; Saccular aneurysm measuring = 3 mm in greatest diameter; Neck aneurysm measuring = 3 mm, or dome-neck ratio = 2; modified Rankin Scale (mRS) prior = 3; Patient agrees and signs the informed consent form

•Any ischemic or hemorrhagic stroke within the last 90 days; Ruptured aneurysm in the last 90 days; Had major surgery that required general anesthesia in the last 90 days; Known clotting disorder; Use of anticoagulants; Platelet count < 100,000 cells/mm3 or known platelet dysfunction; Contraindication to the use of study drugs; Presence of a previous neurostent next to the aneurysm to be treated; Presence of a previous surgical clip next to the aneurysm to be treated causing any stenosis of the carotid artery; Known severe allergy to iodinated contrast media defined by previous occurrence of bronchospasm, laryngospasm, circulatory shock; Chronic kidney disease defined by serum creatinine > 2.5 mg/dL; Pregnancy, lactation, positive pregnancy test; Modified Rankin scale previous from 4 or 5; Any other medical condition that results in a life expectancy = 12 months

发起方

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo